Berlin, 5.-6. February 2019, Mercure Hotel MOA Berlin
Focus on Quality and Standards
After the success of the first symposium, the second symposium focused on three main sessions; (i) in-vivo pre-analytics factors, (ii) ex-vivo pre-analytics factors and (iii) microbiome, covering the most innovative topics in the field currently. The topics of this meeting were presented by experts in their respective domains. The topics included cancer research, which was also the subject of the key note lecture, employing DNA to RNA sequencing and exosome research. Special attention was paid to applications of metabolome and proteome research as well as to specific requirements needed to produce reliable data for the interpretation of our circadian rhythms.
The symposium was co-organized by the German Biobank Node (GBN), a member of the pan-European biobank infrastructure BBMRI-ERIC. Together with a number of biobanks that have joined forces within the German Biobank Alliance (GBA) there is currently establishing a national biobank infrastructure. The biobanks of this alliance are operating in an IT network to enable cross-biobank queries while complying with common quality standards to allow cross-biobank compilation of biomaterial collections.
Biobank Pilsen was presented by two posters:
1) Kinkorova J., Topolcan O., Karlikova M., Kucera R.: Fibroblast Growth Factor (FGF) 23 – Is There Any Potential To Be a Tumor Marker for a Clinical Practice?
2) Svobodova S., Karlikova M., Topolcan O., Pecen L., Pestova M., Kott O., Treska V., Slouka D., Kucera R.: PIVKA-II – a new promising biomarker of hepatocellular carcinoma.
